Meta tags:
description=Independent, document-driven investigative reporting focused on health policy, biotechnology, biosecurity, and government decision-making. Click to read JonFleetwood.com, by Jon Fleetwood, a Substack publication with tens of thousands of subscribers.;
author=Jon Fleetwood;

Headings (most frequently used words):

jonfleetwood, com, subscribe, to, the, why, about, editor, editorial, approach, stay, up, date, join, crew, people,

Text of the page (most frequently used words):
and (27), the (25), reporting (8), fleetwood (7), com (7), health (6), #jonfleetwood (6), about (6), for (5), research (5), jon (4), subscribe (4), policy (4), government (4), has (4), including (4), 2024 (4), substack (3), your (3), investigative (3), biosecurity (3), have (3), news (3), peer (3), reviewed (3), over (3), analysis (3), what (3), legislative (3), vaccine (3), with (3), medical (3), his (3), editor (3), this (2), site (2), javascript (2), home (2), get (2), people (2), independent (2), document (2), driven (2), focused (2), biotechnology (2), decision (2), making (2), newsletter (2), new (2), mainstream (2), publishes (2), primary (2), sources (2), official (2), documents (2), claims (2), those (2), when (2), treatment (2), access (2), based (2), inhaled (2), budesonide (2), work (2), been (2), materials (2), american (2), bill (2), media (2), previously (2), early (2), authored (2), message (2), requires, run, correctly, please, unblock, scripts, turn, great, culture, app, start, collection, notice, terms, privacy, 2026, find, out, more, company, that, provides, tech, visit, part, community, who, share, interests, join, crew, you, won, worry, missing, anything, every, edition, goes, directly, inbox, hidden, studies, challenging, narratives, stay, date, subscriber, supported, continuously, prioritizes, press, releases, narrative, alignment, say, how, are, framed, follows, from, read, carefully, focuses, editorial, approach, addition, contributed, development, templates, related, pharmaceutical, regulation, proposals, addressing, mrna, dna, technologies, counter, availability, these, efforts, involved, consultation, multiple, professionals, submitted, supporting, documentation, contexts, provided, ohio, senate, may, louisiana, house, representatives, select, committee, homeland, security, september, cited, senator, rand, paul, russell, brand, dana, loesch, exposé, frank, speech, martinez, show, zerohedge, children, defense, defender, one, america, nonprofit, organization, appeared, across, range, national, platforms, faith, served, managing, also, reported, administration, live, ebola, healthcare, workers, denver, colorado, amid, construction, high, containment, bat, facility, fort, collins, raising, questions, oversight, risk, proximity, documented, undisclosed, funding, activities, department, agriculture, bird, flu, gain, function, well, provisions, congressional, omnibus, allocating, billion, toward, preparedness, future, avian, influenza, pandemic, examining, clinical, evidence, safety, efficacy, late, covid, paper, was, richard, bartlett, emergency, room, director, recipient, texas, human, services, meritorious, service, award, former, advisor, governor, rick, perry, disparities, task, force, gazette, sciences, june, publication, founder, chief, subscribers, receive, full, ongoing, investigations, source, not, typically, covered, grounded, records, emphasis, explicitly, state, implications, statements, examined, closely, why, send, clicking, below, advertising, sponsorship, opportunities, reaching, 200, 000, viewers, per, month, archive, contact, sponsors, advertisers, instagram, twitter, donate, podcast, sign,

Text of the page (random words):
about jonfleetwood com jonfleetwood com subscribe sign in home podcast donate twitter instagram sponsors advertisers contact archive about for advertising and sponsorship opportunities reaching 200 000 viewers per month send jon a message by clicking below message jon fleetwood why subscribe jonfleetwood com publishes document driven investigative reporting focused on health policy biotechnology biosecurity and government decision making reporting is grounded in primary sources peer reviewed research government records and legislative documents with an emphasis on what official materials explicitly state and the implications of those statements when examined closely subscribers receive full access to ongoing investigations and source based analysis not typically covered by mainstream media about the editor jon fleetwood is the founder and editor in chief of jonfleetwood com in june 2024 fleetwood co authored a peer reviewed medical publication in the gazette of medical sciences examining clinical evidence on the safety and efficacy of inhaled budesonide for early and late treatment of covid 19 the paper was co authored with dr richard bartlett md an emergency room director recipient of the texas health and human services meritorious service award and former advisor to governor rick perry s health disparities task force fleetwood s investigative reporting has documented previously undisclosed government research and funding activities including early reporting on u s department of agriculture bird flu gain of function and vaccine research as well as provisions in the 2024 congressional omnibus bill allocating 1 billion toward preparedness for a future avian influenza pandemic he also reported on the administration of a live ebola vaccine to healthcare workers in denver colorado amid the construction of a high containment bat research facility in fort collins raising questions about biosecurity oversight and risk proximity fleetwood previously served as managing editor at american faith a nonprofit news organization his reporting and analysis have appeared across a range of national media platforms including one america news the defender children s health defense zerohedge the bill martinez show the new american frank speech and the exposé his work has been cited by u s senator rand paul russell brand and dana loesch his work has been submitted as supporting documentation in legislative and policy contexts including materials provided to the ohio senate in may 2024 and to the louisiana house of representatives select committee on homeland security in september 2024 in addition to reporting fleetwood has contributed to the development of legislative policy templates related to pharmaceutical regulation and treatment access including proposals addressing mrna and dna based vaccine technologies and over the counter availability of inhaled budesonide these efforts have involved consultation with multiple medical and research professionals editorial approach jonfleetwood com focuses on what official documents say how claims are framed and what follows from those claims when read carefully reporting prioritizes primary sources over press releases and analysis over narrative alignment the site is independent subscriber supported and publishes continuously stay up to date you won t have to worry about missing anything every new edition of the newsletter goes directly to your inbox get hidden news and peer reviewed studies challenging mainstream health narratives join the crew be part of a community of people who share your interests to find out more about the company that provides the tech for this newsletter visit substack com subscribe to jonfleetwood com independent document driven investigative reporting focused on health policy biotechnology biosecurity and government decision making subscribe people 2026 jon fleetwood privacy terms collection notice start your substack get the app substack is the home for great culture this site requires javascript to run correctly please turn on javascript or unblock scripts